Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Thrombocytopenic Patients With Acute Coronary Syndrome
NCT00501345Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2002
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in myocardial infarction (MI), acute coronary syndrome (ACS), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2002; status: terminated.
02
Drugs
aspirin
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00501345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501345.